| | Planned Parenthood of Greater Texas has filed a lawsuit against the city of Lubbock over an abortion ban voters approved earlier this month. | | | The United States administered COVID-19 vaccinations to around 600,000 children ages 12 to 15 last week after regulators cleared Pfizer Inc's (PFE.N) and BioNTech's shots for use in that age group, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said in a media call on Tuesday. | | | Brazilian senators on Tuesday accused the country's former foreign minister of undermining efforts to obtain COVID-19 vaccines after he used anti-China rhetoric during the pandemic. | | | A federal judge on Tuesday questioned a $2 billion proposal by Bayer AG (BAYGn.DE) that would create a framework for resolving future claims that its Roundup weedkiller causes cancer, casting doubt on the plan a day before a key hearing. | | | The United States has administered 275,535,207 doses of COVID-19 vaccines in the country as of Tuesday morning and distributed 346,672,525 doses, the U.S. Centers for Disease Control and Prevention said on Tuesday. | | | JPMorgan Chase & Co (JPM.N) told employees on Tuesday that fully vaccinated staff do not have to wear masks at its U.S.-based offices, according to an internal memo seen by Reuters. | | | Spain's Health Ministry has proposed that people under 60 who have already received a first dose of AstraZeneca's (AZN.L) drug receive a second shot of the coronavirus vaccine produced by Pfizer (PFE.N), El Pais newspaper reported on Tuesday. | | | Saudi Arabia's interior ministry said on Tuesday that vaccination will be required to enter any governmental, private, or educational establishments and to use public transportation as of August, 1, state news agency (SPA) reported. | | | The pressure on French hospitals from the coronavirus epidemic eased further on Tuesday with the number of COVID-19 patients in intensive care units (ICU) down by 171 to 4,015, as the country prepares for a new easing of coronavirus constraints. | | | Drugmaker Bristol Myers Squibb (BMY.N) will pay biotech firm Agenus Inc (AGEN.O) up to $1.38 billion to exclusively develop and commercialize its experimental cancer drug, AGEN1777, the companies said on Tuesday. | | | | |